Global healthcare firm Novo Nordisk on Thursday said it has appointed Vikrant Shrotriya as Managing Director and Corporate Vice President for India business.
He returns to India after 13 years with an overall career spanning over 20 years in the healthcare industry in India and internationally, Novo Nordisk said in a statement.
Vikrant was recently working in the GCC (Gulf Cooperation Council) countries wherein he was Vice-President for company's GCC business and Corporate Vice President for Saudi Arabia, it added.
"India is an important market for us, and our focus is on enhancing healthcare through awareness and education. We will continue to work on improving access to quality care by working closely with the relevant stakeholders," Shrotriya said.
Novo Nordisk insulins have been presence in India since 1935 and the Indian affiliate was operationalised in 1994.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)